We have recently described the isolation of a novel protein, MIA, which is secreted from malignant melanoma cells and elicits growth inhibition on melanoma cells in vitro (Blesch, A., Bosserhoff, A. K., Apfel, R., Behl, C., Hessdörfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Schlingensiepen, H., Buettner, R., and Bogdahn, U.(1994) Cancer Res. 54, 5695-5701). Here, we report the structure of the human MIA gene locus, describe its expression pattern in melanocytic tumors in vivo, and provide an initial characterization of the MIA promoter. The MIA gene is encoded by four exons, and the mRNA initiation site was identified 70 base pairs upstream from the translation start codon. MIA mRNA expression in vivo correlated with progressive malignancy of melanocytic lesions and was inducible in other cells by phorbol esters. To investigate mechanisms mediating this melanoma-associated expression pattern, we analyzed the promoter activity of the 1.3-kilobase genomic sequences located 5`-upstream of the MIA gene. The MIA promoter conferred high levels of gene activation specifically in human and murine melanoma cells, and its activity was further enhanced by treatment with phorbol esters. Site-directed mutation of an NF-kB site within the MIA promoter did reduce the basal promoter activity in melanoma cells but did not change significantly enhancement by phorbol esters.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				D. Becker, M. C. Mihm, S. M. Hewitt, V. K. Sondak, J. W. Fountain, and M. Thurin Markers and Tissue Resources for Melanoma: Meeting Report. Cancer Res., November 15, 2006; 66(22): 10652 - 10657. [Abstract] [Full Text] [PDF]

				R. Bauer, M. Humphries, R. Fassler, A. Winklmeier, S. E. Craig, and A.-K. Bosserhoff Regulation of Integrin Activity by MIA J. Biol. Chem., April 28, 2006; 281(17): 11669 - 11677. [Abstract] [Full Text] [PDF]

				M. Muhlbauer, B. Allard, A. K. Bosserhoff, S. Kiessling, H. Herfarth, G. Rogler, J. Scholmerich, C. Jobin, and C. Hellerbrand Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-{kappa}B signal transduction and IL-8 gene expression in colonic epithelial cells Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G1000 - G1008. [Abstract] [Full Text] [PDF]

				A. K. Bosserhoff, M. Moser, J. Scholmerich, R. Buettner, and C. Hellerbrand Specific Expression and Regulation of the New Melanoma Inhibitory Activity-related Gene MIA2 in Hepatocytes J. Biol. Chem., April 18, 2003; 278(17): 15225 - 15231. [Abstract] [Full Text] [PDF]

				I. Poser, M. Golob, R. Buettner, and A. K. Bosserhoff Upregulation of HMG1 Leads to Melanoma Inhibitory Activity Expression in Malignant Melanoma Cells and Contributes to Their Malignancy Phenotype Mol. Cell. Biol., April 15, 2003; 23(8): 2991 - 2998. [Abstract] [Full Text] [PDF]

				I. Poser, M. Golob, M. Weidner, R. Buettner, and A. K. Bosserhoff Down-Regulation of COOH-Terminal Binding Protein Expression in Malignant Melanomas Leads to Induction of MIA Expression Cancer Res., October 15, 2002; 62(20): 5962 - 5966. [Abstract] [Full Text] [PDF]

				M. Moser, A.-K. Bosserhoff, E. B. Hunziker, L. Sandell, R. Fassler, and R. Buettner Ultrastructural Cartilage Abnormalities in MIA/CD-RAP-Deficient Mice Mol. Cell. Biol., March 1, 2002; 22(5): 1438 - 1445. [Abstract] [Full Text] [PDF]

				J. C. Lougheed, J. M. Holton, T. Alber, J. F. Bazan, and T. M. Handel Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins PNAS, April 25, 2001; (2001) 91601698. [Abstract] [Full Text]

				M. Deichmann, A. Benner, M. Bock, A. Jackel, K. Uhl, V. Waldmann, and H. Naher S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma J. Clin. Oncol., June 1, 1999; 17(6): 1891 - 1891. [Abstract] [Full Text] [PDF]

				M. Muhlbauer, N. Langenbach, W. Stolz, R. Hein, M. Landthaler, R. Buettner, and A.-K. Bosserhoff Detection of Melanoma Cells in the Blood of Melanoma Patients by Melanoma-inhibitory Activity (MIA) Reverse Transcription-PCR Clin. Cancer Res., May 1, 1999; 5(5): 1099 - 1105. [Abstract] [Full Text] [PDF]

				W.-F. Xie, S. Kondo, and L. J. Sandell Regulation of the Mouse Cartilage-derived Retinoic Acid-sensitive Protein Gene by the Transcription Factor AP-2 J. Biol. Chem., February 27, 1998; 273(9): 5026 - 5032. [Abstract] [Full Text] [PDF]

				M. Cohen-Salmon, D. Frenz, W. Liu, E. Verpy, S. Voegeling, and C. Petit Fdp, a New Fibrocyte-derived Protein Related to MIA/CD-RAP, Has an in Vitro Effect on the Early Differentiation of the Inner Ear Mesenchyme J. Biol. Chem., December 15, 2000; 275(51): 40036 - 40041. [Abstract] [Full Text] [PDF]

				I. Poser, D. Dominguez, A. G. de Herreros, A. Varnai, R. Buettner, and A. K Bosserhoff Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail J. Biol. Chem., June 29, 2001; 276(27): 24661 - 24666. [Abstract] [Full Text] [PDF]

				R. Buettner, G. Papoutsoglou, E. Scemes, D. C. Spray, and R. Dermietzel Evidence for secretory pathway localization of a voltage-dependent anion channel isoform PNAS, March 28, 2000; 97(7): 3201 - 3206. [Abstract] [Full Text] [PDF]

				J. C. Lougheed, J. M. Holton, T. Alber, J. F. Bazan, and T. M. Handel Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins PNAS, May 8, 2001; 98(10): 5515 - 5520. [Abstract] [Full Text] [PDF]